139 related articles for article (PubMed ID: 24109245)
1. Intracameral injection of tissue plasminogen activator to treat severe postoperative fibrinous reaction in iridocorneal endothelial syndrome.
Hong BK; Francis BA
Digit J Ophthalmol; 2013; 19(2):21-3. PubMed ID: 24109245
[TBL] [Abstract][Full Text] [Related]
2. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.
Klais CM; Hattenbach LO; Steinkamp GW; Zubcov AA; Kohnen T
J Cataract Refract Surg; 1999 Mar; 25(3):357-62. PubMed ID: 10079440
[TBL] [Abstract][Full Text] [Related]
3. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery.
Wedrich A; Menapace R; Ries E; Polzer I
J Cataract Refract Surg; 1997; 23(6):873-7. PubMed ID: 9292671
[TBL] [Abstract][Full Text] [Related]
4. Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome.
Dotan A; Kaiserman I; Kremer I; Ehrlich R; Bahar I
Br J Ophthalmol; 2014 Feb; 98(2):252-5. PubMed ID: 24276695
[TBL] [Abstract][Full Text] [Related]
5. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
Schmitz K; Greite JH; Bartenschlager EM
Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
[TBL] [Abstract][Full Text] [Related]
7. Intracameral r-tPA for the management of severe fibrinous reactions in TASS after cataract surgery.
Osaadon P; Belfair N; Lavy I; Walter E; Levy J; Tuuminen R; Achiron A; Knyazer B
Eur J Ophthalmol; 2022 Jan; 32(1):200-204. PubMed ID: 33719630
[TBL] [Abstract][Full Text] [Related]
8. Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report.
Yoshino H; Seki M; Ueda J; Yoshino T; Fukuchi T; Abe H
BMC Ophthalmol; 2012 Mar; 12():3. PubMed ID: 22433746
[TBL] [Abstract][Full Text] [Related]
9. The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery.
Wedrich A; Menapace R; Mühlbauer-Ries E
Int Ophthalmol; 1994-1995; 18(5):277-80. PubMed ID: 7607808
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of intraocular fibrinous membrane by anterior chamber injection of tissue plasminogen activator after IOL implantation].
Xie L; Li S; Dong X; Cao J; Shi W; Guo P
Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):291-3. PubMed ID: 11877211
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis of postcataract fibrin membranes in children.
Mehta JS; Adams GG
J Cataract Refract Surg; 2000 Jan; 26(1):4-5. PubMed ID: 10646131
[No Abstract] [Full Text] [Related]
12. Recombinant tissue plasminogen activator following paediatric cataract surgery.
Mehta JS; Adams GG
Br J Ophthalmol; 2000 Sep; 84(9):983-6. PubMed ID: 10966949
[TBL] [Abstract][Full Text] [Related]
13. Treatment of total hyphema with relatively low-dose tissue plasminogen activator.
Kim MH; Koo TH; Sah WJ; Chung SM
Ophthalmic Surg Lasers; 1998 Sep; 29(9):762-6. PubMed ID: 9760614
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis of postcataract fibrin membranes in children.
Leung AT; Lam DS; Rao SK
J Cataract Refract Surg; 2000 Jan; 26(1):4; author reply 5. PubMed ID: 10646130
[No Abstract] [Full Text] [Related]
15. Tissue plasminogen activator for treatment of fibrin in endophthalmitis.
Damji KF; O'Connor MD; Hill V
Can J Ophthalmol; 2001 Aug; 36(5):269-71. PubMed ID: 11548143
[No Abstract] [Full Text] [Related]
16. Treatment of postcataract fibrinous membranes with tissue plasminogen activator.
Moon J; Chung S; Myong Y; Chung S; Park C; Baek N; Rhee S
Ophthalmology; 1992 Aug; 99(8):1256-9. PubMed ID: 1513579
[TBL] [Abstract][Full Text] [Related]
17. [Tissue plasminogen activator in treatment of fibrinous membranes after cataract surgery].
Oficjalska-Młyńczak J; Marek J; Zajac-Pytrus H; Nizankowska MH; Koziorowska M
Klin Oczna; 1996; 98(6):423-5. PubMed ID: 9340414
[TBL] [Abstract][Full Text] [Related]
18. Management of detached graft donor by SF₆ injection following Descemet stripping automated endothelial keratoplasty of an eye with iridocorneal endothelial syndrome and Ahmed glaucoma drainage tube.
Bozkurt KT; Acar BT; Acar S
Int Ophthalmol; 2012 Dec; 32(6):607-10. PubMed ID: 22752650
[TBL] [Abstract][Full Text] [Related]
19. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification.
Mancuso LA; Nadelstein B; Berdoulay A; Spatola RA
Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778
[TBL] [Abstract][Full Text] [Related]
20. Tissue-plasminogen activator fibrinolysis.
Osher RH
J Cataract Refract Surg; 1999 Jul; 25(7):880. PubMed ID: 10404358
[No Abstract] [Full Text] [Related]
[Next] [New Search]
